Offers
For launching a brand, turning one around (as I did with Kisqali) or accelerating its growth (as with Kesimpta and Promacta). Each one has a defined scope, a fixed timeframe or time commitment, and a clear output. The Launch Readiness Diagnostic is the usual starting point.
30 days
The entry point: an independent read of your launch plan, forecast, access strategy and budget, with the risks that matter most, in order, in writing.
6 weeks
A board-ready U.S. launch plan, built with your team in six weeks.
1–2 days a week
Senior commercial leadership inside your company, part time, to launch, turn around or accelerate a brand. Equity option available.
How we work together
I lead every engagement personally, drawing on three $1B+ brands at Novartis, and stay accountable for the plan and the result.
A short scoping call, then a written proposal with the scope, timing, output and fees. No published prices.
An NDA before details are shared, a conflict check before any engagement, and no client names without written permission.
You get the person who has done it, not a team that studied it. Fixed scope, a written output, and a fee you can approve without a board vote.
What an engagement can look like (illustrative, not a client case): a European biotech preparing its first U.S. launch.
The output: a board-ready plan your team can run.
Why Scalar
You get an excellent plan and a junior team to write it, and the work stops at the readout. I have led three $1B+ brands, and I can stay to run the plan.
A launch fails on access, field size and forecast as often as on message. I have led all of it, plus the P&L.
I don’t sell field forces, hubs or data, so my build-vs-partner advice has no downstream agenda.
I have led brands in Europe, run a $400M P&L across Latin America for Sandoz, and signed 10 licensing and distribution deals, so I can judge build vs. partner from both sides of the table.
Senior specialists
I lead every engagement personally. I bring in trusted senior specialists when a project needs them, for a defined scope you agree in advance, under the same NDA and conflict check.
Questions
Usually with the Launch Readiness Diagnostic. It gives both sides a clear, written view of the business before anyone commits to more, and it is useful on its own.
After a short scoping call, in a written proposal. Fees depend on scope and timing, so they are not published.
One to two days a week, set in the proposal and adjusted as the company’s needs change.
There is an equity option for the fractional role, alongside a cash fee. It is agreed case by case.
Often you should, eventually. A fractional leader makes sense before the full-time role is affordable or clear, or while you search. Handing over to a full-time hire, and helping recruit one, is part of the plan.
An NDA before details are shared, a conflict check before any engagement, and client names are never shared without written permission.
To speed up research, analysis and first drafts, so senior time goes to judgment. Confidential data goes into AI tools only with your approval.
30-minute call with Emilio
Tell me where the business is and what has to happen next. No obligation, and if Scalar isn't the right fit, I'll say so.
I reply personally.